Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous immunoglobulin: a review.

M M Eibl1, R J Wedgwood

  • 1Institute of Immunology, University of Vienna, Austria.

Immunodeficiency Reviews
|January 1, 1989
PubMed
Summary

Intravenous immunoglobulin (IVIG) has replaced older intramuscular products for treating immunodeficiencies and preventing infections. While rare adverse reactions exist, IVIG is generally safe and effective for immune modulation and therapeutic uses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous immunoglobulins in neurological disorders: safety issues.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2003
Same author

Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2003
Same author

Residual expression of functional MHC class II molecules in twin brothers with MHC class II deficiency is cell type specific.

British journal of haematology·2001
Same author

Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.

European journal of gastroenterology & hepatology·2001
Same author

Immune response to the herpes simplex type 1 regulatory proteins ICP8 and VP16 in infected persons.

Journal of medical virology·2000
Same author

Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy.

Urology·2000

Area of Science:

  • Immunology
  • Pharmacology
  • Infectious Diseases

Background:

  • Intramuscular immunoglobulin products are largely superseded by intravenous immunoglobulin (IVIG).
  • Intact immunoglobulin preparations offer full Fc-mediated function and a 3-4 week biological half-life.
  • IVIG administration is now standard for prophylaxis and replacement therapy.

Purpose of the Study:

  • To review the therapeutic applications of IVIG.
  • To summarize IVIG's role in immunodeficiency and infectious disease management.
  • To discuss IVIG's use in immune modulation for autoimmune and immune-complex diseases.

Main Methods:

  • Literature review of IVIG applications.
  • Summary of clinical reports on IVIG efficacy and safety.
  • Analysis of adverse event data, including hepatitis and HIV transmission.

Main Results:

  • IVIG is effective in replacement therapy for primary and secondary immunodeficiencies.
  • IVIG aids in the prevention and treatment of infectious diseases.
  • Adverse reactions to IVIG are infrequent; HIV transmission is undocumented, and non-A, non-B hepatitis is rare.

Conclusions:

  • IVIG is a safe and effective therapeutic agent for various immunological conditions.
  • Intact IVIG preparations are preferred for their functional and pharmacokinetic properties.
  • IVIG demonstrates utility beyond replacement therapy, including immune modulation.

Related Experiment Videos